Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Delayed
TEL AVIV STOCK EXCHANGE
14:33:23 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 10,960.00 ILa | +2.33% |
|
-1.17% | +8.62% |
| 12:51pm | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 10:59am | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| Market Cap | 42.01B 0 36.17B 33.96B 31B 58.24B 3,997B 58.66B 402B 157B 2,027B 158B 154B 6,711B | P/E 2026 * |
48.4x | P/E 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 53.89B 0 46.4B 43.56B 39.77B 74.71B 5,127B 75.24B 516B 201B 2,600B 202B 198B 8,609B | EV / Sales 2026 * |
3.25x | EV / Sales 2027 * | 2.93x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +1.31% | ||
| 1 week | -2.16% | ||
| Current month | -0.18% | ||
| 1 month | -0.18% | ||
| 3 months | +11.57% | ||
| 6 months | +7.85% | ||
| Current year | +7.53% |
| 1 week | 10,780 |  | 11,440 |
| 1 month | 10,180 | | 11,440 |
| Current year | 8,860 | | 11,440 |
| 1 year | 6,082 | | 11,440 |
| 3 years | 3,250 | | 11,440 |
| 5 years | 2,383 | | 11,440 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 31/12/2022 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 21/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 31/12/2008 |
Sol Barer
CHM | Chairman | 78 | 05/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 31/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.40% | -2.16% | - | - | 42.01B | |
| -1.52% | -7.23% | +57.90% | +108.72% | 1,031B | |
| -0.82% | -2.63% | +50.05% | +64.43% | 641B | |
| +0.37% | -3.06% | +21.87% | +74.48% | 453B | |
| -1.43% | -6.32% | +33.36% | +33.31% | 349B | |
| +5.52% | +2.27% | +27.67% | +45.16% | 290B | |
| +0.12% | -1.04% | +1.13% | +12.40% | 252B | |
| -0.59% | -3.15% | +49.83% | +67.70% | 232B | |
| +0.15% | -2.21% | -19.84% | -54.06% | 201B | |
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | |
| Average | +0.73% | -2.98% | +27.98% | +49.28% | 403.31B | |
| Weighted average by Cap. | +0.72% | -3.97% | +37.09% | +65.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.58B 0 14.28B 13.41B 12.24B 22.99B 1,578B 23.15B 159B 61.81B 800B 62.26B 60.91B 2,649B | 17.3B 0 14.9B 13.99B 12.77B 23.99B 1,646B 24.16B 166B 64.5B 835B 64.97B 63.56B 2,764B |
| Net income | 1.44B 0 1.24B 1.17B 1.06B 2B 137B 2.01B 13.81B 5.37B 69.53B 5.41B 5.29B 230B | 2.69B 0 2.31B 2.17B 1.98B 3.73B 256B 3.75B 25.75B 10.02B 130B 10.09B 9.87B 429B |
| Net Debt | 11.88B 0 10.23B 9.6B 8.77B 16.47B 1,130B 16.58B 114B 44.27B 573B 44.6B 43.63B 1,898B | 8.61B 0 7.41B 6.96B 6.35B 11.94B 819B 12.02B 82.49B 32.1B 415B 32.33B 31.63B 1,376B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | ILA 10,960.00 | +2.33% | 594,541 |
| 31/08/26 | ILA 10,710.00 | -2.90% | 905,060 |
| 28/08/26 | ILA 11,030.00 | -1.61% | 1,399,391 |
| 27/08/26 | ILA 11,210.00 | +0.45% | 812,651 |
| 26/08/26 | ILA 11,160.00 | -0.45% | 740,192 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
